 | • レポートコード：QAF27769 • 出版社/出版日：QYResearch / 2021年4月22日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のリンパ腫治療薬市場について種類別（経口、注射）、用途別（ホジキンリンパ腫、非ホジキンリンパ腫）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・リンパ腫治療薬市場の概要 ・世界の主要地域別リンパ腫治療薬市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のリンパ腫治療薬市場規模2016-2021：種類別（経口、注射） ・世界のリンパ腫治療薬市場予測2012-2027：種類別（経口、注射） ・世界のリンパ腫治療薬市場規模2016-2021：用途別（ホジキンリンパ腫、非ホジキンリンパ腫） ・世界のリンパ腫治療薬市場予測2012-2027：用途別（ホジキンリンパ腫、非ホジキンリンパ腫） ・リンパ腫治療薬のアメリカ市場規模と予測2016-2021 ・リンパ腫治療薬のヨーロッパ市場規模と予測2016-2021 ・リンパ腫治療薬の中国市場規模と予測2016-2021 ・リンパ腫治療薬の日本市場規模と予測2016-2021 ・リンパ腫治療薬の東南アジア市場規模と予測2016-2021 ・リンパ腫治療薬のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Roche、CHIPSCREEN、Johnson & Johnson、Abbvie、Celgene） ・リンパ腫治療薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・リンパ腫治療薬の市場動向・機会・課題 ・調査の結論 |
Lymphoma is cancer that begins in infection-fighting cells of the immune system, called lymphocytes. These cells are in the lymph nodes, spleen, thymus, bone marrow, and other parts of the body. When you have lymphoma, lymphocytes change and grow out of control.
The China average price of Lymphoma Drugs is in the decreasing trend, from 1560 USD/Unit in 2013 to 1373 USD/Unit In 2018. With the situation of China economy, prices will be in decreasing trend in the following five years.
Market Analysis and Insights: Global Lymphoma Drugs Market
The global Lymphoma Drugs market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.
Global Lymphoma Drugs Scope and Market Size
The global Lymphoma Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Lymphoma Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Oral
Injection
Segment by Application
Hodgkin Lymphoma
Non-Hodgkin Lymphoma
The Lymphoma Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Lymphoma Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Roche
CHIPSCREEN
Johnson & Johnson
Abbvie
Celgene
1 Lymphoma Drugs Market Overview
1.1 Lymphoma Drugs Product Scope
1.2 Lymphoma Drugs Segment by Type
1.2.1 Global Lymphoma Drugs Sales by Type (2016 & 2021 & 2027)
1.2.2 Oral
1.2.3 Injection
1.3 Lymphoma Drugs Segment by Application
1.3.1 Global Lymphoma Drugs Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hodgkin Lymphoma
1.3.3 Non-Hodgkin Lymphoma
1.4 Lymphoma Drugs Market Estimates and Forecasts (2016-2027)
1.4.1 Global Lymphoma Drugs Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Lymphoma Drugs Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Lymphoma Drugs Price Trends (2016-2027)
2 Lymphoma Drugs Estimates and Forecasts by Region
2.1 Global Lymphoma Drugs Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Lymphoma Drugs Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Lymphoma Drugs Sales Market Share by Region (2016-2021)
2.2.2 Global Lymphoma Drugs Revenue Market Share by Region (2016-2021)
2.3 Global Lymphoma Drugs Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Lymphoma Drugs Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Lymphoma Drugs Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Lymphoma Drugs Estimates and Projections (2016-2027)
2.4.2 Europe Lymphoma Drugs Estimates and Projections (2016-2027)
2.4.3 China Lymphoma Drugs Estimates and Projections (2016-2027)
2.4.4 Japan Lymphoma Drugs Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Lymphoma Drugs Estimates and Projections (2016-2027)
2.4.6 India Lymphoma Drugs Estimates and Projections (2016-2027)
3 Global Lymphoma Drugs Competition Landscape by Players
3.1 Global Top Lymphoma Drugs Players by Sales (2016-2021)
3.2 Global Top Lymphoma Drugs Players by Revenue (2016-2021)
3.3 Global Lymphoma Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Lymphoma Drugs as of 2020)
3.4 Global Lymphoma Drugs Average Price by Company (2016-2021)
3.5 Manufacturers Lymphoma Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Lymphoma Drugs Market Size by Type
4.1 Global Lymphoma Drugs Historic Market Review by Type (2016-2021)
4.1.1 Global Lymphoma Drugs Sales Market Share by Type (2016-2021)
4.1.2 Global Lymphoma Drugs Revenue Market Share by Type (2016-2021)
4.1.3 Global Lymphoma Drugs Price by Type (2016-2021)
4.2 Global Lymphoma Drugs Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Lymphoma Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Lymphoma Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Global Lymphoma Drugs Price Forecast by Type (2022-2027)
5 Global Lymphoma Drugs Market Size by Application
5.1 Global Lymphoma Drugs Historic Market Review by Application (2016-2021)
5.1.1 Global Lymphoma Drugs Sales Market Share by Application (2016-2021)
5.1.2 Global Lymphoma Drugs Revenue Market Share by Application (2016-2021)
5.1.3 Global Lymphoma Drugs Price by Application (2016-2021)
5.2 Global Lymphoma Drugs Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Lymphoma Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Lymphoma Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Lymphoma Drugs Price Forecast by Application (2022-2027)
6 North America Lymphoma Drugs Market Facts & Figures
6.1 North America Lymphoma Drugs Sales by Company
6.1.1 North America Lymphoma Drugs Sales by Company (2016-2021)
6.1.2 North America Lymphoma Drugs Revenue by Company (2016-2021)
6.2 North America Lymphoma Drugs Sales Breakdown by Type
6.2.1 North America Lymphoma Drugs Sales Breakdown by Type (2016-2021)
6.2.2 North America Lymphoma Drugs Sales Breakdown by Type (2022-2027)
6.3 North America Lymphoma Drugs Sales Breakdown by Application
6.3.1 North America Lymphoma Drugs Sales Breakdown by Application (2016-2021)
6.3.2 North America Lymphoma Drugs Sales Breakdown by Application (2022-2027)
7 Europe Lymphoma Drugs Market Facts & Figures
7.1 Europe Lymphoma Drugs Sales by Company
7.1.1 Europe Lymphoma Drugs Sales by Company (2016-2021)
7.1.2 Europe Lymphoma Drugs Revenue by Company (2016-2021)
7.2 Europe Lymphoma Drugs Sales Breakdown by Type
7.2.1 Europe Lymphoma Drugs Sales Breakdown by Type (2016-2021)
7.2.2 Europe Lymphoma Drugs Sales Breakdown by Type (2022-2027)
7.3 Europe Lymphoma Drugs Sales Breakdown by Application
7.3.1 Europe 133 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 133 Sales Breakdown by Application (2022-2027)
8 China Lymphoma Drugs Market Facts & Figures
8.1 China Lymphoma Drugs Sales by Company
8.1.1 China Lymphoma Drugs Sales by Company (2016-2021)
8.1.2 China Lymphoma Drugs Revenue by Company (2016-2021)
8.2 China Lymphoma Drugs Sales Breakdown by Type
8.2.1 China Lymphoma Drugs Sales Breakdown by Type (2016-2021)
8.2.2 China Lymphoma Drugs Sales Breakdown by Type (2022-2027)
8.3 China Lymphoma Drugs Sales Breakdown by Application
8.3.1 China 244 Sales Breakdown by Application (2016-2021)
8.3.2 China 244 Sales Breakdown by Application (2022-2027)
9 Japan Lymphoma Drugs Market Facts & Figures
9.1 Japan Lymphoma Drugs Sales by Company
9.1.1 Japan Lymphoma Drugs Sales by Company (2016-2021)
9.1.2 Japan Lymphoma Drugs Revenue by Company (2016-2021)
9.2 Japan Lymphoma Drugs Sales Breakdown by Type
9.2.1 Japan Lymphoma Drugs Sales Breakdown by Type (2016-2021)
9.2.2 Japan Lymphoma Drugs Sales Breakdown by Type (2022-2027)
9.3 Japan Lymphoma Drugs Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Lymphoma Drugs Market Facts & Figures
10.1 Southeast Asia Lymphoma Drugs Sales by Company
10.1.1 Southeast Asia Lymphoma Drugs Sales by Company (2016-2021)
10.1.2 Southeast Asia Lymphoma Drugs Revenue by Company (2016-2021)
10.2 Southeast Asia Lymphoma Drugs Sales Breakdown by Type
10.2.1 Southeast Asia Lymphoma Drugs Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Lymphoma Drugs Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Lymphoma Drugs Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Lymphoma Drugs Market Facts & Figures
11.1 India Lymphoma Drugs Sales by Company
11.1.1 India Lymphoma Drugs Sales by Company (2016-2021)
11.1.2 India Lymphoma Drugs Revenue by Company (2016-2021)
11.2 India Lymphoma Drugs Sales Breakdown by Type
11.2.1 India Lymphoma Drugs Sales Breakdown by Type (2016-2021)
11.2.2 India Lymphoma Drugs Sales Breakdown by Type (2022-2027)
11.3 India Lymphoma Drugs Sales Breakdown by Application
11.3.1 India Lymphoma Drugs Sales Breakdown by Application (2016-2021)
11.3.2 India Lymphoma Drugs Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Lymphoma Drugs Business
12.1 Roche
12.1.1 Roche Corporation Information
12.1.2 Roche Business Overview
12.1.3 Roche Lymphoma Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Roche Lymphoma Drugs Products Offered
12.1.5 Roche Recent Development
12.2 CHIPSCREEN
12.2.1 CHIPSCREEN Corporation Information
12.2.2 CHIPSCREEN Business Overview
12.2.3 CHIPSCREEN Lymphoma Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 CHIPSCREEN Lymphoma Drugs Products Offered
12.2.5 CHIPSCREEN Recent Development
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Corporation Information
12.3.2 Johnson & Johnson Business Overview
12.3.3 Johnson & Johnson Lymphoma Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Johnson & Johnson Lymphoma Drugs Products Offered
12.3.5 Johnson & Johnson Recent Development
12.4 Abbvie
12.4.1 Abbvie Corporation Information
12.4.2 Abbvie Business Overview
12.4.3 Abbvie Lymphoma Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Abbvie Lymphoma Drugs Products Offered
12.4.5 Abbvie Recent Development
12.5 Celgene
12.5.1 Celgene Corporation Information
12.5.2 Celgene Business Overview
12.5.3 Celgene Lymphoma Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Celgene Lymphoma Drugs Products Offered
12.5.5 Celgene Recent Development
…
13 Lymphoma Drugs Manufacturing Cost Analysis
13.1 Lymphoma Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Lymphoma Drugs
13.4 Lymphoma Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Lymphoma Drugs Distributors List
14.3 Lymphoma Drugs Customers
15 Market Dynamics
15.1 Lymphoma Drugs Market Trends
15.2 Lymphoma Drugs Drivers
15.3 Lymphoma Drugs Market Challenges
15.4 Lymphoma Drugs Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Lymphoma Drugs Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Lymphoma Drugs Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Lymphoma Drugs Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Lymphoma Drugs Sales (K Units) by Region (2016-2021)
Table 5. Global Lymphoma Drugs Sales Market Share by Region (2016-2021)
Table 6. Global Lymphoma Drugs Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Lymphoma Drugs Revenue Share by Region (2016-2021)
Table 8. Global Lymphoma Drugs Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Lymphoma Drugs Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Lymphoma Drugs Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Lymphoma Drugs Revenue Share Forecast by Region (2022-2027)
Table 12. Global Lymphoma Drugs Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Lymphoma Drugs Sales Share by Company (2016-2021)
Table 14. Global Lymphoma Drugs Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Lymphoma Drugs Revenue Share by Company (2016-2021)
Table 16. Global Lymphoma Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lymphoma Drugs as of 2020)
Table 17. Global Lymphoma Drugs Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Lymphoma Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Lymphoma Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Lymphoma Drugs Sales (K Units) by Type (2016-2021)
Table 22. Global Lymphoma Drugs Sales Share by Type (2016-2021)
Table 23. Global Lymphoma Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Lymphoma Drugs Price (USD/Unit) by Type (2016-2021)
Table 25. Global Lymphoma Drugs Sales Share by Type (2022-2027)
Table 26. Global Lymphoma Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Lymphoma Drugs Revenue Share by Type (2022-2027)
Table 28. Global Lymphoma Drugs Price (USD/Unit) by Type (2022-2027)
Table 29. Global Lymphoma Drugs Sales (K Units) by Application (2016-2021)
Table 30. Global Lymphoma Drugs Sales Share by Application (2016-2021)
Table 31. Global Lymphoma Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Lymphoma Drugs Price (USD/Unit) by Application (2016-2021)
Table 33. Global Lymphoma Drugs Sales (K Units) by Application (2022-2027)
Table 34. Global Lymphoma Drugs Sales Share by Application (2022-2027)
Table 35. Global Lymphoma Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Lymphoma Drugs Revenue Share by Application (2022-2027)
Table 37. Global Lymphoma Drugs Price (USD/Unit) by Application (2022-2027)
Table 38. North America Lymphoma Drugs Sales (K Units) by Company (2016-2021)
Table 39. North America Lymphoma Drugs Sales Market Share by Company (2016-2021)
Table 40. North America Lymphoma Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Lymphoma Drugs Revenue Market Share by Company (2016-2021)
Table 42. North America Lymphoma Drugs Sales by Type (2016-2021) & (K Units)
Table 43. North America Lymphoma Drugs Sales Market Share by Type (2016-2021)
Table 44. North America Lymphoma Drugs Sales by Type (2022-2027) & (K Units)
Table 45. North America Lymphoma Drugs Sales Market Share by Type (2022-2027)
Table 46. North America Lymphoma Drugs Sales by Application (2016-2021) & (K Units)
Table 47. North America Lymphoma Drugs Sales Market Share by Application (2016-2021)
Table 48. North America Lymphoma Drugs Sales by Application (2022-2027) & (K Units)
Table 49. North America Lymphoma Drugs Sales Market Share by Application (2022-2027)
Table 50. Europe Lymphoma Drugs Sales (K Units) by Company (2016-2021)
Table 51. Europe Lymphoma Drugs Sales Market Share by Company (2016-2021)
Table 52. Europe Lymphoma Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Lymphoma Drugs Revenue Market Share by Company (2016-2021)
Table 54. Europe Lymphoma Drugs Sales by Type (2016-2021) & (K Units)
Table 55. Europe Lymphoma Drugs Sales Market Share by Type (2016-2021)
Table 56. Europe Lymphoma Drugs Sales by Type (2022-2027) & (K Units)
Table 57. Europe Lymphoma Drugs Sales Market Share by Type (2022-2027)
Table 58. Europe Lymphoma Drugs Sales by Application (2016-2021) & (K Units)
Table 59. Europe Lymphoma Drugs Sales Market Share by Application (2016-2021)
Table 60. Europe Lymphoma Drugs Sales by Application (2022-2027) & (K Units)
Table 61. Europe Lymphoma Drugs Sales Market Share by Application (2022-2027)
Table 62. China Lymphoma Drugs Sales (K Units) by Company (2016-2021)
Table 63. China Lymphoma Drugs Sales Market Share by Company (2016-2021)
Table 64. China Lymphoma Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Lymphoma Drugs Revenue Market Share by Company (2016-2021)
Table 66. China Lymphoma Drugs Sales by Type (2016-2021) & (K Units)
Table 67. China Lymphoma Drugs Sales Market Share by Type (2016-2021)
Table 68. China Lymphoma Drugs Sales by Type (2022-2027) & (K Units)
Table 69. China Lymphoma Drugs Sales Market Share by Type (2022-2027)
Table 70. China Lymphoma Drugs Sales by Application (2016-2021) & (K Units)
Table 71. China Lymphoma Drugs Sales Market Share by Application (2016-2021)
Table 72. China Lymphoma Drugs Sales by Application (2022-2027) & (K Units)
Table 73. China Lymphoma Drugs Sales Market Share by Application (2022-2027)
Table 74. Japan Lymphoma Drugs Sales (K Units) by Company (2016-2021)
Table 75. Japan Lymphoma Drugs Sales Market Share by Company (2016-2021)
Table 76. Japan Lymphoma Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Lymphoma Drugs Revenue Market Share by Company (2016-2021)
Table 78. Japan Lymphoma Drugs Sales by Type (2016-2021) & (K Units)
Table 79. Japan Lymphoma Drugs Sales Market Share by Type (2016-2021)
Table 80. Japan Lymphoma Drugs Sales by Type (2022-2027) & (K Units)
Table 81. Japan Lymphoma Drugs Sales Market Share by Type (2022-2027)
Table 82. Japan Lymphoma Drugs Sales by Application (2016-2021) & (K Units)
Table 83. Japan Lymphoma Drugs Sales Market Share by Application (2016-2021)
Table 84. Japan Lymphoma Drugs Sales by Application (2022-2027) & (K Units)
Table 85. Japan Lymphoma Drugs Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Lymphoma Drugs Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Lymphoma Drugs Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Lymphoma Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Lymphoma Drugs Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Lymphoma Drugs Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Lymphoma Drugs Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Lymphoma Drugs Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Lymphoma Drugs Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Lymphoma Drugs Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Lymphoma Drugs Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Lymphoma Drugs Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Lymphoma Drugs Sales Market Share by Application (2022-2027)
Table 98. India Lymphoma Drugs Sales (K Units) by Company (2016-2021)
Table 99. India Lymphoma Drugs Sales Market Share by Company (2016-2021)
Table 100. India Lymphoma Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Lymphoma Drugs Revenue Market Share by Company (2016-2021)
Table 102. India Lymphoma Drugs Sales by Type (2016-2021) & (K Units)
Table 103. India Lymphoma Drugs Sales Market Share by Type (2016-2021)
Table 104. India Lymphoma Drugs Sales by Type (2022-2027) & (K Units)
Table 105. India Lymphoma Drugs Sales Market Share by Type (2022-2027)
Table 106. India Lymphoma Drugs Sales by Application (2016-2021) & (K Units)
Table 107. India Lymphoma Drugs Sales Market Share by Application (2016-2021)
Table 108. India Lymphoma Drugs Sales by Application (2022-2027) & (K Units)
Table 109. India Lymphoma Drugs Sales Market Share by Application (2022-2027)
Table 110. Roche Corporation Information
Table 111. Roche Description and Business Overview
Table 112. Roche Lymphoma Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Roche Lymphoma Drugs Product
Table 114. Roche Recent Development
Table 115. CHIPSCREEN Corporation Information
Table 116. CHIPSCREEN Description and Business Overview
Table 117. CHIPSCREEN Lymphoma Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. CHIPSCREEN Lymphoma Drugs Product
Table 119. CHIPSCREEN Recent Development
Table 120. Johnson & Johnson Corporation Information
Table 121. Johnson & Johnson Description and Business Overview
Table 122. Johnson & Johnson Lymphoma Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Johnson & Johnson Lymphoma Drugs Product
Table 124. Johnson & Johnson Recent Development
Table 125. Abbvie Corporation Information
Table 126. Abbvie Description and Business Overview
Table 127. Abbvie Lymphoma Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Abbvie Lymphoma Drugs Product
Table 129. Abbvie Recent Development
Table 130. Celgene Corporation Information
Table 131. Celgene Description and Business Overview
Table 132. Celgene Lymphoma Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Celgene Lymphoma Drugs Product
Table 134. Celgene Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Lymphoma Drugs Distributors List
Table 138. Lymphoma Drugs Customers List
Table 139. Lymphoma Drugs Market Trends
Table 140. Lymphoma Drugs Market Drivers
Table 141. Lymphoma Drugs Market Challenges
Table 142. Lymphoma Drugs Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Lymphoma Drugs Product Picture
Figure 2. Global Lymphoma Drugs Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Lymphoma Drugs Sales Market Share by Application in 2021 & 2027
Figure 6. Hodgkin Lymphoma Examples
Figure 7. Non-Hodgkin Lymphoma Examples
Figure 8. Global Lymphoma Drugs Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Lymphoma Drugs Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Lymphoma Drugs Sales (K Units) Growth Rate (2016-2027)
Figure 11. Global Lymphoma Drugs Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 12. Global Lymphoma Drugs Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Lymphoma Drugs Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Lymphoma Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Lymphoma Drugs Sales (K Units) Growth Rate (2016-2027)
Figure 16. Europe Lymphoma Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Lymphoma Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Lymphoma Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Lymphoma Drugs Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Lymphoma Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Lymphoma Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Lymphoma Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Lymphoma Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Lymphoma Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Lymphoma Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Lymphoma Drugs Players Market Share by Revenue in Lymphoma Drugs: 2016 & 2020
Figure 27. Lymphoma Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Lymphoma Drugs Revenue Share by Type (2016-2021)
Figure 29. Global Lymphoma Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Lymphoma Drugs Revenue Share by Application (2016-2021)
Figure 31. Global Lymphoma Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Lymphoma Drugs Sales Market Share by Type in 2020
Figure 33. North America Lymphoma Drugs Sales Market Share by Application in 2020
Figure 34. Europe Lymphoma Drugs Sales Market Share by Type in 2020
Figure 35. Europe Lymphoma Drugs Sales Market Share by Application in 2020
Figure 36. China Lymphoma Drugs Sales Market Share by Type in 2020
Figure 37. China Lymphoma Drugs Sales Market Share by Application in 2020
Figure 38. Japan Lymphoma Drugs Sales Market Share by Type in 2020
Figure 39. Japan Lymphoma Drugs Sales Market Share by Application in 2020
Figure 40. Southeast Asia Lymphoma Drugs Sales Market Share by Type in 2020
Figure 41. Southeast Asia Lymphoma Drugs Sales Market Share by Application in 2020
Figure 42. India Lymphoma Drugs Sales Market Share by Type in 2020
Figure 43. India Lymphoma Drugs Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Lymphoma Drugs
Figure 46. Manufacturing Process Analysis of Lymphoma Drugs
Figure 47. Lymphoma Drugs Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
世界の非ホジキンリンパ腫＆慢性リンパ腫治療市場規模・現状・予測（2021年-2027年） Non-Hodgkins Lymphoma also known as NHL is a heterogeneous and complex group of disorders that are characterized by clonal proliferation of lymphocytes at multiple stages of maturation. There are approximately 30 types of NHLs with varying pathological, clinical, and genetic features. Chronic Lympho…- 世界のB細胞非ホジキンリンパ腫（NHL）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market The global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy…
- 世界の非ホジキンリンパ腫治療市場規模・現状・予測（2021年-2027年） Non-Hodgkin’s lymphomas are one of the most commonly occurring cases of lymphomas and hence is also one of the most commonly occurring cancers. If not treated effectively, it is potentially lethal and leads to a shorter life span of the individuals diagnosed. Market Analysis and Insights: Global Non…
- 世界の未分化大細胞リンパ腫市場規模・現状・予測（2021年-2027年） Anaplastic large cell lymphoma (ALCL) is a rare type of non-Hodgkin lymphoma (NHL), and one of the subtypes of T-cell lymphoma. Market Analysis and Insights: Global Anaplastic Large Cell Lymphoma Market The global Anaplastic Large Cell Lymphoma market size is projected to reach US$ XX million by 202…
- 世界のBCL-2（B細胞リンパ腫2）阻害剤市場規模・現状・予測（2021年-2027年） Bcl-2 (B-cell lymphoma 2), encoded in humans by the BCL2 gene, is the founding member of the Bcl-2 family of regulator proteins that regulate cell death (apoptosis), by either inhibiting (anti-apoptotic) or inducing (pro-apoptotic) apoptosis. Market Analysis and Insights: Global BCL-2 (B-cell lympho…